Mesoblast (MESO) Consolidated Net Income: 2014-2023
Historic Consolidated Net Income for Mesoblast (MESO) over the last 8 years, with Jun 2023 value amounting to -$21.6 million.
- Mesoblast's Consolidated Net Income fell 2.34% to -$21.6 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$81.9 million, marking a year-over-year increase of 10.35%. This contributed to the annual value of -$102.1 million for FY2025, which is 16.13% down from last year.
- Latest data reveals that Mesoblast reported Consolidated Net Income of -$21.6 million as of Q2 2023, which was down 15.42% from -$18.7 million recorded in Q1 2023.
- Mesoblast's Consolidated Net Income's 5-year high stood at -$9.3 million during Q3 2019, with a 5-year trough of -$29.4 million in Q1 2019.
- For the 3-year period, Mesoblast's Consolidated Net Income averaged around -$22.0 million, with its median value being -$21.5 million (2022).
- Its Consolidated Net Income has fluctuated over the past 5 years, first skyrocketed by 55.32% in 2019, then crashed by 178.18% in 2020.
- Over the past 5 years, Mesoblast's Consolidated Net Income (Quarterly) stood at -$29.1 million in 2019, then increased by 12.03% to -$25.6 million in 2020, then fell by 1.90% to -$26.1 million in 2021, then rose by 5.66% to -$24.6 million in 2022, then fell by 2.34% to -$21.6 million in 2023.
- Its last three reported values are -$21.6 million in Q2 2023, -$18.7 million for Q1 2023, and -$24.6 million during Q4 2022.